These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16186409)

  • 1. A -30G>A polymorphism of the beta-cell-specific glucokinase promoter associates with hyperglycemia in the general population of whites.
    Rose CS; Ek J; Urhammer SA; Glümer C; Borch-Johnsen K; Jørgensen T; Pedersen O; Hansen T
    Diabetes; 2005 Oct; 54(10):3026-31. PubMed ID: 16186409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the glucokinase gene promoter polymorphism -30G > A (rs1799884) with gestational diabetes mellitus susceptibility: a case-control study and meta-analysis.
    Han X; Cui H; Chen X; Xie W; Chang Y
    Arch Gynecol Obstet; 2015 Aug; 292(2):291-8. PubMed ID: 25633883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic regulation of birth weight and fasting glucose by a common polymorphism in the islet cell promoter of the glucokinase gene.
    Weedon MN; Frayling TM; Shields B; Knight B; Turner T; Metcalf BS; Voss L; Wilkin TJ; McCarthy A; Ben-Shlomo Y; Davey Smith G; Ring S; Jones R; Golding J; Byberg L; Mann V; Axelsson T; Syvänen AC; Leon D; Hattersley AT
    Diabetes; 2005 Feb; 54(2):576-81. PubMed ID: 15677518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A variation at position -30 of the beta-cell glucokinase gene promoter is associated with reduced beta-cell function in middle-aged Japanese-American men.
    Stone LM; Kahn SE; Fujimoto WY; Deeb SS; Porte D
    Diabetes; 1996 Apr; 45(4):422-8. PubMed ID: 8603762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population.
    Vaxillaire M; Cavalcanti-Proença C; Dechaume A; Tichet J; Marre M; Balkau B; Froguel P;
    Diabetes; 2008 Aug; 57(8):2253-7. PubMed ID: 18556336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A -243A-->G polymorphism upstream of the gene encoding GAD65 associates with lower levels of body mass index and glycaemia in a population-based sample of 5857 middle-aged White subjects.
    Boesgaard TW; Castella SI; Andersen G; Albrechtsen A; Sparsø T; Borch-Johnsen K; Jørgensen T; Hansen T; Pedersen O
    Diabet Med; 2007 Jul; 24(7):702-6. PubMed ID: 17459095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of Japanese men with glucokinase gene beta-cell promoter variant.
    Yamada K; Yuan X; Ishiyama S; Ichikawa F; Koyama KI; Koyanagi A; Koyama W; Nonaka K
    Diabetes Care; 1997 Jul; 20(7):1159-61. PubMed ID: 9203455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucokinase gene islet promoter region variant (G-->A) at nucleotide -30 is not associated with reduced insulin secretion in Finns.
    Rissanen J; Saarinen L; Heikkinen S; Kekäläinen P; Mykkänen L; Kuusisto J; Deeb SS; Laakso M
    Diabetes Care; 1998 Jul; 21(7):1194-7. PubMed ID: 9653619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphism of glucokinase on the risk of type 2 diabetes and impaired glucose regulation: evidence based on 298,468 subjects.
    Fu D; Cong X; Ma Y; Cai H; Cai M; Li D; Lv M; Yuan X; Huang Y; Lv Z
    PLoS One; 2013; 8(2):e55727. PubMed ID: 23441155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic glucokinase promoter polymorphism is associated with hepatic insulin resistance in Asian Indians.
    Chiu KC; Chuang LM; Yoon C; Saad MF
    BMC Genet; 2000; 1():2. PubMed ID: 11112984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperglycemia caused by mutation of GCK gene in 10 patients analysis of clinical and mutation characteristics].
    Zhang J; Yuan K; Ding SX; Kong YM; Zhu JF; Fang YL; Liang L; Fu JF; Wang CL
    Zhonghua Er Ke Za Zhi; 2019 Jun; 57(6):440-444. PubMed ID: 31216801
    [No Abstract]   [Full Text] [Related]  

  • 12. The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes.
    Sparsø T; Andersen G; Nielsen T; Burgdorf KS; Gjesing AP; Nielsen AL; Albrechtsen A; Rasmussen SS; Jørgensen T; Borch-Johnsen K; Sandbaek A; Lauritzen T; Madsbad S; Hansen T; Pedersen O
    Diabetologia; 2008 Jan; 51(1):70-5. PubMed ID: 18008060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Type 2 diabetes on Glucokinase diabetes (GCK-MODY) phenotype in a Roma (Gypsy) family - case report.
    Stanik J; Kusekova M; Huckova M; Valentinova L; Masindova I; Stanikova D; Ferenczova J; Gasperikova D; Klimes I
    Endocr Regul; 2012 Apr; 46(2):99-105. PubMed ID: 22540858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fasting hyperglycaemia and polymorphism in glucokinase promoter (rs1799884)].
    Bahíllo Curieses P; Hermoso López F; Garrote Molpeceres R; Zurita Muñoz O; Campos Barros A
    An Pediatr (Barc); 2011 Oct; 75(4):273-6. PubMed ID: 21697023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PNPLA3 rs738409 G-allele associates with reduced fasting serum triglyceride and serum cholesterol in Danes with impaired glucose regulation.
    Krarup NT; Grarup N; Banasik K; Friedrichsen M; Færch K; Sandholt CH; Jørgensen T; Poulsen P; Witte DR; Vaag A; Sørensen T; Pedersen O; Hansen T
    PLoS One; 2012; 7(7):e40376. PubMed ID: 22792295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel beta-cell glucokinase (GCK) promoter mutation (-71G>C) that modulates GCK gene expression through loss of allele-specific Sp1 binding causing mild fasting hyperglycemia in humans.
    Gasperíková D; Tribble ND; Staník J; Hucková M; Misovicová N; van de Bunt M; Valentínová L; Barrow BA; Barák L; Dobránsky R; Bereczková E; Michálek J; Wicks K; Colclough K; Knight JC; Ellard S; Klimes I; Gloyn AL
    Diabetes; 2009 Aug; 58(8):1929-35. PubMed ID: 19411616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The -30G>A polymorphism of the glucokinase gene promoter is associated with obesity in a population from southern Spain.
    Gómez-Zumaquero JM; Rojo-Martínez G; García-Escobar E; Martín-Nuñez GM; Haro J; Esteva I; Ruiz de Adana M; Cuesta AL; Olveira G; Morcillo S; Soriguer F
    Obesity (Silver Spring); 2008 Aug; 16(8):1973-5. PubMed ID: 18483479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.
    Pearson ER; Velho G; Clark P; Stride A; Shepherd M; Frayling TM; Bulman MP; Ellard S; Froguel P; Hattersley AT
    Diabetes; 2001 Feb; 50 Suppl 1():S101-7. PubMed ID: 11272165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects.
    Tam CH; Ho JS; Wang Y; Lee HM; Lam VK; Germer S; Martin M; So WY; Ma RC; Chan JC; Ng MC
    PLoS One; 2010 Jul; 5(7):e11428. PubMed ID: 20628598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucokinase-maturity onset diabetes mellitus in the young suggested by factory-calibrated glucose monitoring data: a case report.
    Nomura N; Iizuka K; Goshima E; Hosomichi K; Tajima A; Kubota S; Liu Y; Takao K; Kato T; Mizuno M; Hirota T; Suwa T; Horikawa Y; Yabe D
    Endocr J; 2022 Apr; 69(4):473-477. PubMed ID: 34803122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.